To amend the Federal Food, Drug, and Cosmetic Act to establish additional authorities of the Food and Drug Administration regarding the conduct of pediatric investigations of molecularly targeted drugs to treat cancer, and for other purposes.
About This Bill
Committee
Latest Action · May 12, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.